Savant Capital LLC lowered its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 7.0% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 36,940 shares of the company's stock after selling 2,799 shares during the period. Savant Capital LLC's holdings in Cardinal Health were worth $4,369,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Angeles Wealth Management LLC acquired a new position in Cardinal Health in the 4th quarter valued at about $205,000. Kestra Private Wealth Services LLC grew its position in shares of Cardinal Health by 23.7% during the 4th quarter. Kestra Private Wealth Services LLC now owns 16,593 shares of the company's stock worth $1,962,000 after purchasing an additional 3,177 shares in the last quarter. Miller Howard Investments Inc. NY acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $573,000. Entropy Technologies LP acquired a new position in shares of Cardinal Health during the 4th quarter worth approximately $1,596,000. Finally, Wilmington Savings Fund Society FSB grew its position in shares of Cardinal Health by 2.8% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 7,870 shares of the company's stock worth $931,000 after purchasing an additional 211 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.
Cardinal Health Trading Down 0.3 %
NYSE:CAH traded down $0.44 on Friday, hitting $126.35. The company had a trading volume of 1,620,302 shares, compared to its average volume of 2,327,426. The stock has a market capitalization of $30.52 billion, a price-to-earnings ratio of 23.57, a PEG ratio of 1.49 and a beta of 0.63. The firm has a 50 day moving average of $122.85 and a two-hundred day moving average of $116.30. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $132.84.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, equities analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.60%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is currently 37.69%.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. Wells Fargo & Company increased their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a research report on Tuesday, February 4th. Barclays increased their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research report on Monday, November 4th. Mizuho assumed coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They set an "outperform" rating and a $139.00 target price on the stock. TD Cowen upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Citigroup upped their price target on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a report on Friday, January 10th. Four equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $136.87.
Check Out Our Latest Report on Cardinal Health
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
